New pill aims to tame severe eczema itch and rash
NCT ID NCT07216027
Summary
This study is testing whether an experimental daily pill called PF-08049820 is safe and effective for adults with moderate to severe eczema (atopic dermatitis). About 200 participants will take either the study pill or a placebo (a pill with no medicine) for 12 weeks. Doctors will check their skin and symptoms to see if the pill helps reduce itching and rashes better than the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Science Institute
Santa Monica, California, 90404, United States
-
Dermatology and Ophthalmology Kume Clinic
Sakai, Osaka, 593-8324, Japan
-
Fukuwa Clinic
Chuo-ku, Tokyo, 104-0031, Japan
-
Goodlettsville Dermatology Research
Goodlettsville, Tennessee, 37072, United States
-
Gsi Clinical Research
Margate, Florida, 33063, United States
-
Hattori Dermatology Clinic
Takasaki, Gunma, 370-0071, Japan
-
Kosugi Dermatology Clinic
Kawasaki-shi, Kanagawa, 211-0063, Japan
-
Nihonbashi Sakura Clinic
Chuo-ku, Tokyo, 103-0025, Japan
-
Queen's Square Medical Facilities
Yokohama, Kanagawa, 220-6208, Japan
-
Skin Research of South Florida
Miami, Florida, 33173, United States
Conditions
Explore the condition pages connected to this study.